These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating Disorder. Statnick MA, Chen Y, Ansonoff M, Witkin JM, Rorick-Kehn L, Suter TM, Song M, Hu C, Lafuente C, Jiménez A, Benito A, Diaz N, Martínez-Grau MA, Toledo MA, Pintar JE. J Pharmacol Exp Ther; 2016 Feb; 356(2):493-502. PubMed ID: 26659925 [Abstract] [Full Text] [Related]
6. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system. Thomas RC, Bath MF, Stover CM, Lambert DG, Thompson JP. Peptides; 2014 Nov; 61():56-60. PubMed ID: 25161013 [Abstract] [Full Text] [Related]
7. Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111. Marti M, Mela F, Budri M, Volta M, Malfacini D, Molinari S, Zaveri NT, Ronzoni S, Petrillo P, Calò G, Morari M. Br J Pharmacol; 2013 Feb; 168(4):863-79. PubMed ID: 22994368 [Abstract] [Full Text] [Related]
9. Fear expression is reduced after acute and repeated nociceptin/orphanin FQ (NOP) receptor antagonism in rats: therapeutic implications for traumatic stress exposure. Taylor RM, Jeong IH, May MD, Bergman EM, Capaldi VF, Moore NLT, Matson LM, Lowery-Gionta EG. Psychopharmacology (Berl); 2020 Oct; 237(10):2943-2958. PubMed ID: 32588078 [Abstract] [Full Text] [Related]
10. Nociceptin/orphanin FQ neurons in the Arcuate Nucleus and Ventral Tegmental Area Act via Nociceptin Opioid Peptide Receptor Signaling to Inhibit Proopiomelanocortin and A10 Dopamine Neurons and Thereby Modulate Ingestion of Palatable Food. Hernandez J, Perez L, Soto R, Le N, Gastelum C, Wagner EJ. Physiol Behav; 2021 Jan 01; 228():113183. PubMed ID: 32979341 [Abstract] [Full Text] [Related]
11. Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease. Arcuri L, Viaro R, Bido S, Longo F, Calcagno M, Fernagut PO, Zaveri NT, Calò G, Bezard E, Morari M. Neurobiol Dis; 2016 May 01; 89():55-64. PubMed ID: 26804029 [Abstract] [Full Text] [Related]
13. Caloric restriction increases the sensitivity to the hyperphagic effect of nociceptin/orphanin FQ limiting its ability to reduce binge eating in female rats. Micioni Di Bonaventura MV, Ubaldi M, Liberati S, Ciccocioppo R, Massi M, Cifani C. Psychopharmacology (Berl); 2013 Jul 01; 228(1):53-63. PubMed ID: 23455592 [Abstract] [Full Text] [Related]
14. Investigation of a role for ghrelin signaling in binge-like feeding in mice under limited access to high-fat diet. King SJ, Rodrigues T, Watts A, Murray E, Wilson A, Abizaid A. Neuroscience; 2016 Apr 05; 319():233-45. PubMed ID: 26791525 [Abstract] [Full Text] [Related]
15. Effects of CB1 and CRF1 receptor antagonists on binge-like eating in rats with limited access to a sweet fat diet: lack of withdrawal-like responses. Parylak SL, Cottone P, Sabino V, Rice KC, Zorrilla EP. Physiol Behav; 2012 Sep 10; 107(2):231-42. PubMed ID: 22776620 [Abstract] [Full Text] [Related]
17. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies. Spagnolo B, Carrà G, Fantin M, Fischetti C, Hebbes C, McDonald J, Barnes TA, Rizzi A, Trapella C, Fanton G, Morari M, Lambert DG, Regoli D, Calò G. J Pharmacol Exp Ther; 2007 Jun 10; 321(3):961-7. PubMed ID: 17329552 [Abstract] [Full Text] [Related]
18. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders. Ubaldi M, Cannella N, Borruto AM, Petrella M, Micioni Di Bonaventura MV, Soverchia L, Stopponi S, Weiss F, Cifani C, Ciccocioppo R. Int J Mol Sci; 2021 Nov 30; 22(23):. PubMed ID: 34884757 [Abstract] [Full Text] [Related]